Co-Authors
This is a "connection" page, showing publications co-authored by Mario Cozzolino and Claudio Ronco.
Connection Strength
2.705
-
Rationale for Medium Cutoff Membranes in COVID-19 Patients Requiring Renal Replacement Therapy. Nephron. 2020; 144(11):550-554.
Score: 0.896
-
The COVID-19 infection in dialysis: are home-based renal replacement therapies a way to improve patient management? J Nephrol. 2020 08; 33(4):629-631.
Score: 0.895
-
Clinical Management of Chronic Kidney Disease Patients in Italy: Results from the IRIDE Study. Nephron. 2018; 140(1):39-47.
Score: 0.194
-
[Non vitamin-K dependent oral anticoagulants (NOACs) in chronic kidney disease patients with non-valvular atrial fibrillation]. G Ital Nefrol. 2017 Apr; 34(2):58-73.
Score: 0.178
-
The treatment of type 2 diabetes mellitus in patients with chronic kidney disease: What to expect from new oral hypoglycemic agents. Diabetes Metab Syndr. 2017 Nov; 11 Suppl 1:S295-S305.
Score: 0.177
-
[NOACs and Chronic kidney disease]. G Ital Nefrol. 2017 Mar; 34(Suppl 69):188-204.
Score: 0.177
-
The Cost of Patients with Chronic Kidney Failure Before Dialysis: Results from the IRIDE Observational Study. Pharmacoecon Open. 2018 Dec; 2(4):459-467.
Score: 0.050
-
Chronic Hyperkalemia in Cardiorenal Patients: Risk Factors, Diagnosis, and New Treatment Options. Cardiorenal Med. 2019; 9(1):8-21.
Score: 0.049
-
[Neprilysin inhibition and chronic kidney disease]. G Ital Nefrol. 2017 Sep 28; 34(5):102-112.
Score: 0.046
-
[Newer anti - diabetic therapies and chronic kidney disease]. G Ital Nefrol. 2017 Jan-Feb; 34(1).
Score: 0.044